经皮微波消融治疗极早期肝癌102例疗效分析

摘要

Objective To investigate the effects and prognostic factors for the survival in the patients with very-early stage hepatocellular carcinoma (HCC) treated with percutaneous microwave ablation. Methods From January 2007 to January 2012,102 cases of very-early stage HCC were treated by percutaneous microwave ablation. Complete ablation rate,overall survival rate,disease-free survival rate were observed and analyzed. Results The complete ablation rate was 96.1%. The 1- ,3- ,and 5-year overall survival ratet and corresponding disease-free survival rate was 94.1%, 84.3%, 72.5% and 90.2%, 73.5%, 59.2% respectively. Conclusion Percutaneous microwave ablation is a safe and efficient therapy for very-early stage HCC.%目的 评估经皮微波消融治疗极早期肝癌的疗效并行预后相关因素分析.方法 2007年1月至2012年1月,第二军医大学东方肝胆外科医院对收治的102例极早期肝癌病人行微波消融治疗,统计分析其完全消融率、总体存活率、无病存活率.结果 截至随访结束,全组肿瘤完全消融率96.1%,1、3、5年总体存活率和无瘤存活率分别为94.1%、84.3%、72.5%和90.2%、73.5%、59.2%.结论 经皮微波消融是治疗极早期肝癌安全、有效的方式.